916596-04-8

Basic information

• Product Name: 3-chloro-4-isopropoxybenzonitrile
• Synonyms: 3-chloro-4-isopropoxybenzonitrile
• CAS NO: 916596-04-8
• Molecular Weight: 195.648
• Mol File: 916596-04-8.mol

Chemical Properties

• CAS DataBase Reference: 3-chloro-4-isopropoxybenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-4-isopropoxybenzonitrile(916596-04-8)
• EPA Substance Registry System: 3-chloro-4-isopropoxybenzonitrile(916596-04-8)

Safety Data

• Hazardous Substances Data: 916596-04-8(Hazardous Substances Data)

Upstream product

• 2315-81-3 2-chloro-4-cyanophenol 
• 75-26-3 isopropyl bromide 
• 117482-84-5 3-chloro-4-fluorobenzonitrile 
• 67-63-0 isopropyl alcohol 

Downstream Products

• 1035216-81-9 (Z)-3-chloro-N'-hydroxy-4-isopropoxybenzimidamide 
• 1035214-17-5 3-(3-chloro-4-isopropoxyphenyl)-5-(3-chloropyridin-4-yl)-[1,2,4]-oxadiazole 
• 213598-06-2 methyl 3-chloro-4-isopropoxybenzoate 
• 213598-07-3 3-chloro-4-isopropoxy-benzoic acid 
• 1035216-81-9 3-chloro-N'-hydroxy-4-isopropoxy-benzamidine 
• 1035212-67-9 4-[3-(3-chloro-4-isopropoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-3-methyl-pyridine 
• 1035216-68-2 (Z)-3-(4-(3-(3-chloro-4-isopropoxyphenyl)-1,2,4-oxadiazol-5-yl)phenyl)acrylic acid 
• 1035216-54-6 (Z)-methyl 3-(4-(3-(3-chloro-4-isopropoxyphenyl)-1,2,4-oxadiazol-5-yl)phenyl)acrylate 
• 1035216-52-4 3-(4-(3-(3-chloro-4-isopropoxyphenyl)-1,2,4-oxadiazol-5-yl)benzylamino)propane-1,2-diol 

Relevant articles and documents

A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066

Recently we reported the discovery of a potent and selective CK2α inhibitor CAM4066. This compound inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket). Here we describe in detail the journey that led to the discov

THIADIAZOLE MODULATORS OF S1P AND METHODS OF MAKING AND USING

The invention is directed to compounds of the formula: wherein each of the variables are defined herein, as well as methods of making and using the compounds as agonists of S1P1 and/or S1P5 for instance treating an autoimmune disease.

OXADIAZOLE MODULATORS OF S1P METHODS OF MAKING AND USING

The invention is directed to Compounds of Formula (I): wherein each variable is defined herein, as well as methods of making and using the compounds as agonists of S1P1 and/or S1P5 for instance for treating graft versus host disease and autoimmune diseases.

Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P3-sparing S1P1 agonists

We have previously disclosed 1,2,4-oxadiazole derivative 3 as a potent S1P3-sparing S1P1 agonist. Although compound 3 exhibits potent and manageable immunosuppressive efficacy in various in vivo models, recent studies have revealed that its 1,2,4-oxadiazole ring is subjected to enterobacterial decomposition. As provisions for unpredictable issues, a series of alternative compounds were synthesized on the basis of compound 3. Extensive SAR studies led to the finding of 1,3-thiazole 24c with the EC50 value of 3.4 nM for human S1P1, and over 5800-fold selectivity against S1P3. In rat on host versus graft reaction (HvGR), the ID50 value of 24c was determined at 0.07 mg/kg. The pharmacokinetics in rat and monkey is also reported. Compared to compound 3, 24c showed excellent stability against enterobacteria.

NOVEL OXADIAZOLE COMPOUNDS

Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation o

NOVEL OXADIAZOLE COMPOUNDS

Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation o